| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.62 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |